Table 2.

Cytomegalovirus Molecular & serological Prevalence by Respondent Characteristics among Pregnant Women, Gorgan, Iran, May 2018 to September 2018.

	Sample Size	CMV Positive		IgG Positive		IgM Positive
Item	N (%)	N (%)	P.value χ2	N (%)	P.value χ2	N (%)	P.value χ2
Behavioral Factors
Anal intercourse:			0.4		0.4		0.5
Yes	51 (16.1%)	10 (19.6%)		43 (84.3%)		1 (2.0%)
No	264(83.2%)	41 (15.5%)		233 (88.3%)		9 (3.4%)
Condom use			0.08		0.6		0.1
Yes	49 (15.6%)	12 (24.5%)		42 (85.7%)		0
No	264(83.8%)	39 (14.7%)		234(88.0%)		10 (3.8%)
Age at first sexual intercourse			0.5		0.8		0.5
<20	159 (50.4%)	24 (15.1%)		140 (88.1%)		4 (2.5%)
≥20	156 (49.5%)	27 (17.3%)		136 (87.2%)		6 (3.8%)
Clinical Factors
Trimester of pregnancy			0.1		0.3		0.1
1st	29 (9.2%)	1 (3.4%)		23 (79.3%)		2 (6.9%)
2nd	11 (3.5%)	2 (18.2%)		10 (90.9%)		0
3rd	275 (87.3%)	48 (17.5%)		243 (88.4%)		8 (2.9%)
Mode of delivery			0.2		0.6		0.04
Vaginal	148 (46.9%)	25 (16.9%)		131 (88.5%)		7 (4.7%)
Cesarean	152 (48.2%)	26 (17.1%)		133 (87.5%)		2 (1.3%)
Abortion	15 (4.8%)	0		12 (80.0%)		1 (6.7%)
History of abortion			0.4		0.5		0.4
Yes	94 (29.8%)	13 (13.8%)		84 (89.4%)		4 (4.3%)
No	221(70.1%)	38 (17.2%)		192 (86.9%)		6 (2.7%)
Unusual discharge			0.5		0.5		0.9
Yes	123 (39.0%)	22 (17.9%)		106 (86.2%)		4 (3.3%)
No	192 (60.9%)	29 (15.1%)		170 (88.5%)		6 (3.1%)
Sex pain:			0.8		0.3		0.5
Yes	91 (28.9%)	14 (15.4%)		77 (84.6%)		2 (2.2%)
No	224 (71.1%)	37 (16.5%)		199 (88.8%)		8 (3.6%)
Pop smear			0.8		0.1		0.2
Yes	76 (24.1%)	13 (17.1%)		63 (82.9%)		4 (5.3%)
No	239 (75.8%)	38 (15.9%)		213 (89.1%)		6 (2.5%)

Abbreviations: CMV: Cytomegalovirus